PPRS - The Pharmaceutical Price Regulation Scheme

The Pharmaceutical Price Regulation Scheme (PPRS) has been in operation in various forms since 1957, and has always been a voluntary scheme negotiated and agreed between the ABPI and the DH. Recently, the scheme has been underpinned by statute (section 33-38 of the Health Act 1999) giving the DH power to secure the compliance of manufacturers with the scheme.

Objectives of the PPRS

The NHS is the ultimate payer of all medicines which are supplied to the UK market, that do not go to the private sector, OTC or are exported. The DH therefore have a responsibility to the Treasury to ensure that drug costs are contained within certain parameters while balancing this against the pharmaceutical industry's high contribution to the gross domestic product and general inward investment in the UK.

How we can help you?

With over 10 years of practical experience of PPRS compliance and first hand experience of face to face negotiation with the Department of Healt, we can offer you the following services:

• Clarification of your responsibilities under the scheme rules
• Interpretation of all, or elements of the scheme rules
• PPRS training and awareness for Senior Executives or staff responsible for PPRS compliance
• Advice on specific matters relating to compliance
• Advice on the pricing of new products or line extensions
• Review of your portfolio for modulation opportunities (where relevant)
• Full AFR and modulation reporting, including supplementary quarterly reporting of sales (where relevant)
• Negotiation on your behalf with the PPRS division of the DH
• Introductions to the principal negotiators in the PPRS branch of the DH
• Ensure any changes made to your supply chain are reflected in any PPRS decision making.

If there is advice you require outside of the above summarised list of services, please contact us.